Kennedy Capital Management, Inc. X4 Pharmaceuticals, Inc Transaction History

Kennedy Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.88 - $1.91 $100,186 - $217,449	-113,848 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.48 - $2.58 $26,126 - $45,544	-17,653 Reduced 13.42%	113,848 $199,000
Q4 2021 Feb 14, 2022	BUY	$1.9 - $5.6 $249,851 - $736,405	131,501 New	131,501 $301,000

107

101M

418K

71.7K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $45.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.